How Trelagliptin controls blood sugar

After the human body eats, the blood sugar level rises. The secretion of intestinal insulin from the small intestine can promote the secretion of insulin and inhibit the secretion of glucagon, so it has the effect of lowering the blood sugar level. But trypsin is quickly broken down in the body by an enzyme called "DPP-4". Trelagliptin, as a DPP-4 inhibitor, continuously promotes insulin secretion by inhibiting DPP-4 enzyme degradation of intestinal insulin, thereby achieving the purpose of continuously inhibiting glucagon secretion and lowering blood sugar. Another benefit of trolagliptin in lowering blood sugar is that it will not cause hypoglycemia. Intestinal trypsin is only produced when the body's blood sugar rises after eating. Intestinal trypsin is not produced during normal blood sugar and hypoglycemia. At this time, DPP-4 inhibitors do not have a hypoglycemic effect.